These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 20813141)

  • 21. Screening the Medicines for Malaria Venture Pathogen Box for invasion and egress inhibitors of the blood stage of Plasmodium falciparum reveals several inhibitory compounds.
    Dans MG; Weiss GE; Wilson DW; Sleebs BE; Crabb BS; de Koning-Ward TF; Gilson PR
    Int J Parasitol; 2020 Mar; 50(3):235-252. PubMed ID: 32135179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of Plasmodium falciparum dUTPase as the target of 5'-tritylated deoxyuridine analogues with anti-malarial activity.
    Pérez-Moreno G; Sánchez-Carrasco P; Ruiz-Pérez LM; Johansson NG; Müller S; Baragaña B; Hampton SE; Gilbert IH; Kaiser M; Sarkar S; Pandurangan T; Kumar V; González-Pacanowska D
    Malar J; 2019 Dec; 18(1):392. PubMed ID: 31796083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Searching for new antimalarial therapeutics amongst known drugs.
    Weisman JL; Liou AP; Shelat AA; Cohen FE; Guy RK; DeRisi JL
    Chem Biol Drug Des; 2006 Jun; 67(6):409-16. PubMed ID: 16882315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimalarial activities of aminooxy compounds.
    Berger BJ
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2540-2. PubMed ID: 10952611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Small Molecules Disrupting the Ubiquitin Proteasome System in Malaria.
    Mata-Cantero L; Chaparro MJ; Colmenarejo G; Cid C; Cortes Cabrera A; Rodriguez MS; Martín J; Gamo FJ; Gomez-Lorenzo MG
    ACS Infect Dis; 2019 Dec; 5(12):2105-2117. PubMed ID: 31644867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbial inhibitors active against Plasmodium falciparum dihydroorotate dehydrogenase derived from an Indonesian soil fungus, Talaromyces pinophilus BioMCC-f.T.3979.
    Pramisandi A; Dobashi K; Mori M; Nonaka K; Matsumoto A; Tokiwa T; Higo M; Kristiningrum ; Amalia E; Nurkanto A; Inaoka DK; Waluyo D; Kita K; Nozaki T; Ōmura S; Shiomi K
    J Gen Appl Microbiol; 2020 Nov; 66(5):273-278. PubMed ID: 32669511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Selective Inhibitors of
    Harupa A; De Las Heras L; Colmenarejo G; Lyons-Abbott S; Reers A; Caballero Hernandez I; Chung CW; Charter D; Myler PJ; Fernández-Menéndez RM; Calderón F; Palomo S; Rodríguez B; Berlanga M; Herreros-Avilés E; Staker BL; Fernández Álvaro E; Kaushansky A
    J Med Chem; 2020 Jan; 63(2):591-600. PubMed ID: 31850752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A chemical susceptibility profile of the Plasmodium falciparum transmission stages by complementary cell-based gametocyte assays.
    D'Alessandro S; Camarda G; Corbett Y; Siciliano G; Parapini S; Cevenini L; Michelini E; Roda A; Leroy D; Taramelli D; Alano P
    J Antimicrob Chemother; 2016 May; 71(5):1148-58. PubMed ID: 26888912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Selective Inhibitors of the Plasmodium falciparum Hexose Transporter PfHT by Screening Focused Libraries of Anti-Malarial Compounds.
    Ortiz D; Guiguemde WA; Johnson A; Elya C; Anderson J; Clark J; Connelly M; Yang L; Min J; Sato Y; Guy RK; Landfear SM
    PLoS One; 2015; 10(4):e0123598. PubMed ID: 25894322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiplasmodial drug targets: a patent review (2000 - 2013).
    Okombo J; Chibale K
    Expert Opin Ther Pat; 2016; 26(1):107-30. PubMed ID: 26566576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Plasmodium dipeptidyl aminopeptidase allosteric inhibitors by high throughput screening.
    Sanchez MI; de Vries LE; Lehmann C; Lee JT; Ang KK; Wilson C; Chen S; Arkin MR; Bogyo M; Deu E
    PLoS One; 2019; 14(12):e0226270. PubMed ID: 31851699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional screening of selective mitochondrial inhibitors of Plasmodium.
    Gomez-Lorenzo MG; Rodríguez-Alejandre A; Moliner-Cubel S; Martínez-Hoyos M; Bahamontes-Rosa N; Gonzalez Del Rio R; Ródenas C; Fuente J; Lavandera JL; García-Bustos JF; Mendoza-Losana A
    Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):295-303. PubMed ID: 29775797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemoprotective antimalarials identified through quantitative high-throughput screening of Plasmodium blood and liver stage parasites.
    Dorjsuren D; Eastman RT; Wicht KJ; Jansen D; Talley DC; Sigmon BA; Zakharov AV; Roncal N; Girvin AT; Antonova-Koch Y; Will PM; Shah P; Sun H; Klumpp-Thomas C; Mok S; Yeo T; Meister S; Marugan JJ; Ross LS; Xu X; Maloney DJ; Jadhav A; Mott BT; Sciotti RJ; Winzeler EA; Waters NC; Campbell RF; Huang W; Simeonov A; Fidock DA
    Sci Rep; 2021 Jan; 11(1):2121. PubMed ID: 33483532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of New Compounds Active against Plasmodium falciparum by High Throughput Screening of Microbial Natural Products.
    Pérez-Moreno G; Cantizani J; Sánchez-Carrasco P; Ruiz-Pérez LM; Martín J; El Aouad N; Pérez-Victoria I; Tormo JR; González-Menendez V; González I; de Pedro N; Reyes F; Genilloud O; Vicente F; González-Pacanowska D
    PLoS One; 2016; 11(1):e0145812. PubMed ID: 26735308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fragment-Based Screening of a Natural Product Library against 62 Potential Malaria Drug Targets Employing Native Mass Spectrometry.
    Vu H; Pedro L; Mak T; McCormick B; Rowley J; Liu M; Di Capua A; Williams-Noonan B; Pham NB; Pouwer R; Nguyen B; Andrews KT; Skinner-Adams T; Kim J; Hol WGJ; Hui R; Crowther GJ; Van Voorhis WC; Quinn RJ
    ACS Infect Dis; 2018 Apr; 4(4):431-444. PubMed ID: 29436819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological characterization of chemically diverse compounds targeting the Plasmodium falciparum coenzyme A synthesis pathway.
    Fletcher S; Lucantoni L; Sykes ML; Jones AJ; Holleran JP; Saliba KJ; Avery VM
    Parasit Vectors; 2016 Nov; 9(1):589. PubMed ID: 27855724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 6-oxopurine phosphoribosyltransferase: a target for the development of antimalarial drugs.
    de Jersey J; Holý A; Hocková D; Naesens L; Keough DT; Guddat LW
    Curr Top Med Chem; 2011; 11(16):2085-102. PubMed ID: 21619515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasmodium falciparum dihydroorotate dehydrogenase: a drug target against malaria.
    Hoelz LV; Calil FA; Nonato MC; Pinheiro LC; Boechat N
    Future Med Chem; 2018 Aug; 10(15):1853-1874. PubMed ID: 30019917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Plasmodium falciparum specific translation inhibitors from the MMV Malaria Box using a high throughput in vitro translation screen.
    Ahyong V; Sheridan CM; Leon KE; Witchley JN; Diep J; DeRisi JL
    Malar J; 2016 Mar; 15():173. PubMed ID: 26987601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Novel Plasmodium falciparum Hexokinase Inhibitors with Antiparasitic Activity.
    Davis MI; Patrick SL; Blanding WM; Dwivedi V; Suryadi J; Golden JE; Coussens NP; Lee OW; Shen M; Boxer MB; Hall MD; Sharlow ER; Drew ME; Morris JC
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6023-33. PubMed ID: 27458230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.